Literature DB >> 26488324

The "Death Diamond": Rapid thrombelastography identifies lethal hyperfibrinolysis.

Michael P Chapman1, Ernest E Moore, Hunter B Moore, Eduardo Gonzalez, Alexander P Morton, James Chandler, Courtney D Fleming, Arsen Ghasabyan, Christopher C Silliman, Anirban Banerjee, Angela Sauaia.   

Abstract

BACKGROUND: Postinjury hyperfibrinolysis (HF), defined as LY30 of 3% or greater on rapid thrombelastography (rTEG), is associated with high mortality and large use of blood products. We observed that some cases of HF are reversible and are associated with patients who respond to hemostatic resuscitation; however, other cases of severe HF seem to be associated with these patients' inevitable demise. We therefore sought to define this unsurvivable subtype of HF as a recognizable rTEG tracing pattern.
METHODS: We queried our trauma registry for patients who either died or spent at least 1 day in the intensive care unit, received at least 1 U of packed red blood cells, and had an admission rTEG. Within this group of 572 patients, we identified 42 pairs of nonsurvivors and survivors who matched on age, sex, injury mechanism, and New Injury Severity Score (NISS). We inspected the rTEG tracings to ascertain if any pattern was found exclusively within the nonsurviving group and applied these findings to the cohort of 572 patients to assess the predictive value for mortality.
RESULTS: Within the matched group, 17% of the patients developed HF. Within the HF subgroup, a unique rTEG pattern was present in 14 HF patients who died and in none of the survivors. This pattern was a "diamond-shaped" tracing with a short time to maximum amplitude of 14 minutes or shorter and complete lysis before the LY30 point. When these criteria are applied to the 572 unmatched patients, this pattern had a 100% positive predictive value for mortality.
CONCLUSION: Patients displaying the "death diamond" pattern on their admission rTEG are at higher risk for mortality. Given the volume of blood products and other resources that these patients consume, this thrombelastography pattern may represent an objective criterion to discontinue efforts at hemostatic resuscitation. LEVEL OF EVIDENCE: Prognostic/epidemiologic study, level III.

Entities:  

Mesh:

Year:  2015        PMID: 26488324      PMCID: PMC4684985          DOI: 10.1097/TA.0000000000000871

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  21 in total

1.  Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study.

Authors:  Jonathan J Morrison; Joseph J Dubose; Todd E Rasmussen; Mark J Midwinter
Journal:  Arch Surg       Date:  2011-10-17

Review 2.  Towards hemostatic resuscitation: the changing understanding of acute traumatic biology, massive bleeding, and damage-control resuscitation.

Authors:  Mitchell Jay Cohen
Journal:  Surg Clin North Am       Date:  2012-08       Impact factor: 2.741

3.  The significance of coagulative and thrombotic changes after haemorrhage and injury.

Authors:  R M Hardaway
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1970

4.  Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy.

Authors:  Michael P Chapman; Ernest E Moore; Christopher R Ramos; Arsen Ghasabyan; Jeffrey N Harr; Theresa L Chin; John R Stringham; Angela Sauaia; Christopher C Silliman; Anirban Banerjee
Journal:  J Trauma Acute Care Surg       Date:  2013-12       Impact factor: 3.313

5.  Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.

Authors:  Haleema Shakur; Ian Roberts; Raúl Bautista; José Caballero; Tim Coats; Yashbir Dewan; Hesham El-Sayed; Tamar Gogichaishvili; Sanjay Gupta; Jorge Herrera; Beverley Hunt; Pius Iribhogbe; Mario Izurieta; Hussein Khamis; Edward Komolafe; María-Acelia Marrero; Jorge Mejía-Mantilla; Jaime Miranda; Carlos Morales; Oluwole Olaomi; Fatos Olldashi; Pablo Perel; Richard Peto; P V Ramana; R R Ravi; Surakrant Yutthakasemsunt
Journal:  Lancet       Date:  2010-06-14       Impact factor: 79.321

6.  The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.

Authors:  Ian Roberts; Haleema Shakur; Adefemi Afolabi; Karim Brohi; Tim Coats; Yashbir Dewan; Satoshi Gando; Gordon Guyatt; B J Hunt; Carlos Morales; Pablo Perel; David Prieto-Merino; Tom Woolley
Journal:  Lancet       Date:  2011-03-26       Impact factor: 79.321

7.  Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration.

Authors:  Bryan A Cotton; John A Harvin; Vadim Kostousouv; Kristin M Minei; Zayde A Radwan; Herbert Schöchl; Charles E Wade; John B Holcomb; Nena Matijevic
Journal:  J Trauma Acute Care Surg       Date:  2012-08       Impact factor: 3.313

8.  Criteria for empiric treatment of hyperfibrinolysis after trauma.

Authors:  Matthew E Kutcher; Michael W Cripps; Ryan C McCreery; Ian M Crane; Molly D Greenberg; Leslie M Cachola; Brittney J Redick; Mary F Nelson; Mitchell Jay Cohen
Journal:  J Trauma Acute Care Surg       Date:  2012-07       Impact factor: 3.313

9.  Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy.

Authors:  Hunter B Moore; Ernest E Moore; Eduardo Gonzalez; Michael P Chapman; Theresa L Chin; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2014-12       Impact factor: 3.313

Review 10.  The coagulopathy of trauma: a review of mechanisms.

Authors:  John R Hess; Karim Brohi; Richard P Dutton; Carl J Hauser; John B Holcomb; Yoram Kluger; Kevin Mackway-Jones; Michael J Parr; Sandro B Rizoli; Tetsuo Yukioka; David B Hoyt; Bertil Bouillon
Journal:  J Trauma       Date:  2008-10
View more
  11 in total

1.  [Uncritical use of tranexamic acid in trauma patients : Do no further harm!]

Authors:  M Maegele
Journal:  Unfallchirurg       Date:  2016-11       Impact factor: 1.000

2.  Redefining postinjury fibrinolysis phenotypes using two viscoelastic assays.

Authors:  Gregory R Stettler; Ernest E Moore; Hunter B Moore; Geoffrey R Nunns; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2019-04       Impact factor: 3.313

3.  Rotational thromboelastometry significantly optimizes transfusion practices for damage control resuscitation in combat casualties.

Authors:  Nicolas J Prat; Andrew D Meyer; Nichole K Ingalls; Julie Trichereau; Joseph J DuBose; Andrew P Cap
Journal:  J Trauma Acute Care Surg       Date:  2017-09       Impact factor: 3.313

Review 4.  [Viscoelasticity-based treatment of bleeding injuries].

Authors:  Marc Maegele; Michael Caspers; Herbert Schöchl
Journal:  Unfallchirurg       Date:  2017-09       Impact factor: 1.000

Review 5.  Hemorrhagic blood failure: Oxygen debt, coagulopathy, and endothelial damage.

Authors:  Nathan J White; Kevin R Ward; Shibani Pati; Geir Strandenes; Andrew P Cap
Journal:  J Trauma Acute Care Surg       Date:  2017-06       Impact factor: 3.313

Review 6.  Viscoelastic testing inside and beyond the operating room.

Authors:  Liang Shen; Sheida Tabaie; Natalia Ivascu
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

7.  The α-globin chain of hemoglobin potentiates tissue plasminogen activator induced hyperfibrinolysis in vitro.

Authors:  Alexander P Morton; Jamie B Hadley; Arsen Ghasabyan; Marguerite R Kelher; Ernest E Moore; Shaun Bevers; Monika Dzieciatkowska; Kirk C Hansen; Mitchell S Cohen; Anirban Banerjee; Christopher C Silliman
Journal:  J Trauma Acute Care Surg       Date:  2022-01-01       Impact factor: 3.697

8.  Apolipoprotein A-I, elevated in trauma patients, inhibits platelet activation and decreases clot strength.

Authors:  Wilbert L Jones; Christopher R Ramos; Anirban Banerjee; Ernest E Moore; Kirk C Hansen; Julia R Coleman; Marguerite Kelher; Keith B Neeves; Christopher C Silliman; Jorge Di Paola; Brian Branchford
Journal:  Platelets       Date:  2022-06-05       Impact factor: 4.236

9.  Systemic hyperfibrinolysis after trauma: a pilot study of targeted proteomic analysis of superposed mechanisms in patient plasma.

Authors:  Anirban Banerjee; Christopher C Silliman; Ernest E Moore; Monika Dzieciatkowska; Marguerite Kelher; Angela Sauaia; Kenneth Jones; Michael P Chapman; Eduardo Gonzalez; Hunter B Moore; Angelo D'Alessandro; Erik Peltz; Benjamin E Huebner; Peter Einerson; James Chandler; Arsen Ghasabayan; Kirk Hansen
Journal:  J Trauma Acute Care Surg       Date:  2018-06       Impact factor: 3.313

Review 10.  Optimizing transfusion strategies in damage control resuscitation: current insights.

Authors:  Timothy H Pohlman; Alison M Fecher; Cecivon Arreola-Garcia
Journal:  J Blood Med       Date:  2018-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.